Medicare

Matrix Medical Network Selects Carenet Health to Enhance and Personalize Member Outreach

Retrieved on: 
Tuesday, April 30, 2024
State, System, Health education, Safety, Health, Medicaid, ACA, Partnership, Medicare Advantage, Patient, Medicare, Practitioner, Multimedia, Quality of life, Organization, Nursing

SCOTTSDALE, Ariz., April 30, 2024 /PRNewswire/ -- Matrix Medical Network® (Matrix), a leader in delivering high quality, home-based health and care services today further affirms its commitment to enhanced member engagement as it formalizes a strategic partnership with Carenet Health (Carenet). As part of this collaboration, Carenet, who enables the business of healthcare, will provide Matrix with customized, tech-integrated, person-to-person outreach and engagement designed to activate members and positively impact lives and outcomes.

Key Points: 
  • SCOTTSDALE, Ariz., April 30, 2024 /PRNewswire/ -- Matrix Medical Network® (Matrix), a leader in delivering high quality, home-based health and care services today further affirms its commitment to enhanced member engagement as it formalizes a strategic partnership with Carenet Health (Carenet).
  • Matrix Medical Network affirms its commitment to enhanced member engagement with a partnership with Carenet Health.
  • Matrix Medical Network is an independent, at scale provider of comprehensive in-home health assessments in the U.S.
  • *Matrix Medical Network is the registered trademark of Community Care Health Network, LLC.

ReNew Health to Pay $7 Million to Settle First-of-its-Kind COVID-19 False Claims Act Case

Retrieved on: 
Tuesday, April 30, 2024
SNF, Courage, CMS, Person, Learning, Pneumonia, State, Reed, Nursing, Medicaid, Medicare (United States), False Claims Act, Injury, Senior, COVID-19, Splenic infarction, Medicare, Judgement, Government, Pharmaceutical industry

MINNEAPOLIS, Minn., April 29, 2024 /PRNewswire-PRWeb/ -- Zimmerman Reed announced today that the United States and the State of California reached a $7 million settlement with ReNew Health Group LLC, ReNew Health Consulting Services LLC, and its owner-CEO and its COO to resolve False Claims Act allegations filed by Zimmerman Reed's whistleblower clients. ReNew Health, the owner and operator of dozens of nursing facilities throughout California, allegedly submitted millions of dollars of fraudulent claims to Medicare and California Medicaid since March 2020 under a scheme involving a COVID-19 waiver program.

Key Points: 
  • Zimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program.
  • "This case emphasizes the vital contribution that whistleblowers can make in exposing healthcare fraud," said June Hoidal, chair of Zimmerman Reed's Whistleblower practice.
  • "The courage of our clients who reported improper Medicare and Medicaid claims was instrumental in bringing this case to light and securing a just result."
  • The federal False Claims Act and its state law equivalents empower private citizens to sue on the government's behalf against persons who present false claims for payment under government contracts or programs.

ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices

Retrieved on: 
Monday, April 29, 2024
FDA, Congress, Laboratory, ARUP, CLEP, MDA, MD, Doctor of Philosophy, Synovial joint, ARUP Laboratories, Patient, Medicare, Health, Medical device

SALT LAKE CITY, April 29, 2024 /PRNewswire/ -- A final FDA rule regulating laboratory-developed tests (LDTs) as medical devices does not address serious concerns raised by ARUP Laboratories and the clinical laboratory community, and the company's stance on the rule has not changed, CEO Andy Theurer said today.

Key Points: 
  • SALT LAKE CITY, April 29, 2024 /PRNewswire/ -- A final FDA rule regulating laboratory-developed tests (LDTs) as medical devices does not address serious concerns raised by ARUP Laboratories and the clinical laboratory community, and the company's stance on the rule has not changed, CEO Andy Theurer said today.
  • "ARUP is evaluating and reviewing the final rule, including any changes, internally and with our industry partners, to determine next steps," Theurer said.
  • Congress gave the FDA authority to regulate medical devices, but if Congress had intended the FDA to regulate laboratory-developed testing services as medical devices, lawmakers would have included this concept in the text of the Medical Device Amendments of 1976 (MDA), and it did not.
  • He added that he and ARUP Chief Compliance Officer Jonathan Carr will host an educational webinar on the FDA rule.

AANA Presents U.S. Representative Jen Kiggans With National Health Leadership Award

Retrieved on: 
Monday, April 29, 2024
Education, Congress, Congressional district, Assembly, DNP, Veterans' affairs, Health, Gallup, American Medical Association, Doctor of Philosophy, House, Human, ICAN, Federation, Patient, Legislation, Society, Access, American Society of Anesthesiologists, Medicare, Committee, Certified Registered Nurse Anesthetist, Multimedia, ASA, Licensure, Nursing

ROSEMONT, Ill., April 29, 2024 /PRNewswire/ -- (AANA) – The American Association of Nurse Anesthesiology (AANA) recognized U.S. Representative Jen Kiggans (R-VA) as the winner of its National Health Leadership Award for 2024 at its Mid-Year Assembly, April 20-24, in Washington, DC.

Key Points: 
  • ROSEMONT, Ill., April 29, 2024 /PRNewswire/ -- (AANA) – The American Association of Nurse Anesthesiology (AANA) recognized U.S. Representative Jen Kiggans (R-VA) as the winner of its National Health Leadership Award for 2024 at its Mid-Year Assembly, April 20-24, in Washington, DC.
  • The National Health Leadership Award was established in 1992 and is presented to individuals working at the federal government level who have made a significant contribution to the formation of national health policy.
  • Kiggans is a freshman representative, serving Virginia's 2nd Congressional District.
  • I am honored to receive the AANA National Health Leadership Award and will continue to work across the aisle to pass legislation to improve nursing recruitment, education, and retention."

The Association for Diagnostics & Laboratory Medicine (formerly AACC) opposes FDA ruling on laboratory developed tests; urges FDA to involve all stakeholders in modernization of laboratory developed test regulation in order to preserve patient access to v

Retrieved on: 
Monday, April 29, 2024
FDA, CMS, Food, Health, Clinical Laboratory, Medical laboratory, AACC, Diagnosis, Patient, Medicare, Communication

Only by having a collaborative discussion can we craft thoughtful and sensible updates to laboratory developed test regulations that advance patient safety while also safeguarding patient access to these essential tests.

Key Points: 
  • Only by having a collaborative discussion can we craft thoughtful and sensible updates to laboratory developed test regulations that advance patient safety while also safeguarding patient access to these essential tests.
  • "As it stands, the FDA's rule would limit patient access to laboratory developed tests.
  • After this phaseout, the FDA will require laboratory developed tests to meet the agency's regulatory standards.
  • As a result, once the phaseout period ends, labs will be faced with significant delays in getting FDA authorization for their laboratory developed tests.

Honest Medical Group Names Robert Bessler, MD as CEO

Retrieved on: 
Monday, April 29, 2024
Sound, Environment, Bessler, Physician, MD, Medicare, Senior advisor, Patient, Hospital

NASHVILLE, Tenn., April 29, 2024 /PRNewswire/ -- Honest Medical Group ("Honest"), a physician led value-based care enablement organization, today announced the appointment of Robert Bessler, MD as Chief Executive Officer (CEO) and member of the Board of Directors.

Key Points: 
  • NASHVILLE, Tenn., April 29, 2024 /PRNewswire/ -- Honest Medical Group ("Honest"), a physician led value-based care enablement organization, today announced the appointment of Robert Bessler, MD as Chief Executive Officer (CEO) and member of the Board of Directors.
  • Robert Bessler, MD succeeds Aric Coffman, MD who will remain a Senior Advisor to Honest.
  • Robert Bessler, MD brings over two decades of experience building and growing health care companies, along with deep industry relationships.
  • In 2001, Robert Bessler, MD founded Sound Physicians ("Sound"), a physician led multi-specialty medical group, where he served as the CEO and Chairman for 22 years.

Nearly Two-Thirds of People on Weight Loss Drugs Stop Due to Side Effects, Other Concerns

Retrieved on: 
Monday, April 29, 2024
C-peptide, Inflammation, Pancreas, Nausea, BMI, Stomach, Diabetes, Medicaid, Weight loss, Insurance, Human, Gastroparesis, Obesity, Disease, Exercise, Science, Patient, Diarrhea, Medicare, Constipation, HealthCentral, Health insurance

ARLINGTON, Va., April 29, 2024 /PRNewswire/ -- The majority of patients prescribed weight loss drugs for obesity stop taking them because of side effects and cost, according to the results of a new survey from HealthCentral, a leading digital platform focused on informing and empowering people with chronic and serious disease. 

Key Points: 
  • More than 28% said they stopped taking the drugs due to side effects, while one in four said they stopped for other reasons, which included cost.
  • The drugs are often not covered by health insurers and neither Medicare nor Medicaid cover the drugs for weight loss.
  • Only 11% said they stopped because the medication did not help them lose weight, while 35% said the drugs worked for them and they remain on them.
  • The cost of GLP-1 drugs influences how patients with obesity view the medications.

Introducing Jeffery Walker's Financial Services: Empowering Financial Success

Retrieved on: 
Monday, April 29, 2024
Education, Knowledge, Retirement, Heart, Empowerment, Medicare, Trust

MOUNTAIN VIEW, Wyo., April 29, 2024 /PRNewswire/ -- Jeffery Walker proudly announces the launch of Jeffrey Walker Financial Services, a comprehensive solution designed to empower individuals and families with essential financial guidance.

Key Points: 
  • MOUNTAIN VIEW, Wyo., April 29, 2024 /PRNewswire/ -- Jeffery Walker proudly announces the launch of Jeffrey Walker Financial Services, a comprehensive solution designed to empower individuals and families with essential financial guidance.
  • Situated in the heart of Southwest Wyoming, Jeffery Walker is poised to revolutionize the landscape of financial planning by prioritizing education and personalized strategies over sales-driven approaches.
  • As a veteran in the financial planning industry, Jeffery Walker understands the significance of informed decision-making.
  • Rather than focusing solely on transactions, he emphasizes the importance of education, helping clients understand their financial options, and empowering them to make sound choices.

Two South Florida Doctors Open New MDVIP-Affiliated Primary Care Practices

Retrieved on: 
Monday, April 29, 2024
Patient, Obesity medicine, Nursing care plan, Pharmacy, Health, Anesthesiology, Insomnia, Physician, Medicare, Internal medicine, MDVIP, Nursing

BOCA RATON, Fla., April 29, 2024 /PRNewswire/ -- MDVIP, the market leader in personalized healthcare with a network of over 1,100 physicians nationwide, today announced the opening of two new MDVIP-affiliated practices in South Florida. Emily Salmon-Denikos, M.D., a family physician in Lake Worth, and Dimitri M. Gitelmaker, M.D., a board-certified internist and obesity medicine specialist in Hollywood, have each joined the MDVIP network and are currently accepting patients who want a more direct relationship with their primary care doctor.

Key Points: 
  • , a board-certified internist and obesity medicine specialist in Hollywood, have each joined the MDVIP network and are currently accepting patients who want a more direct relationship with their primary care doctor.
  • MDVIP-affiliated physicians offer a solution to the many frustrations that patients can experience with traditional primary care, including long waits to schedule an appointment, rushed visits and difficulty getting all of their concerns addressed.
  • "With experience in anesthesiology and critical care, I am well versed in pulmonary and cardiac health.
  • Eleven peer-reviewed, published studies show that patients in MDVIP-affiliated practices have better health outcomes compared to those in traditional primary care practices, including:
    79% fewer hospitalizations for Medicare patients, equating to $600 million savings in one year

Petauri™ Announces 2 Key Hires at Petauri Advisors

Retrieved on: 
Monday, April 29, 2024
CVS, University, Pharmacy, Amylin Pharmaceuticals, Mentorship, Care Act 2014, Pharmacist, Medicare Part D, Novartis, SVP, Pfizer, Senior, AMCP, Medicare, Marketing, MBA, Affordable Care Act, Pharmaceutical industry

NASHVILLE, Tenn., April 29, 2024 /PRNewswire/ -- Petauri Advisors, a strategic life sciences consulting business unit of Petauri, a leading purpose-built pharmaceutical services platform, announced today that it has added to its executive ranks 2 experienced leaders who bring extensive market access experience and expertise comprising implementation of Medicare Part D, the Affordable Care Act, and brand marketing.

Key Points: 
  • Petauri Advisors has added Gina Valerio and Joe Honcz to its ranks as VP and SVP, respectively.
  • Given her deep expertise in market access and brand marketing strategy, along with her profound understanding of the evolving healthcare landscape, Gina will be a highly valued partner to Petauri Advisors clients navigating today's market access challenges.
  • Before joining Petauri, Gina provided strategic market access consultative services to various pharmaceutical and life sciences companies in the San Diego area.
  • "With their proven track record across the continuum of managed care, Gina and Joe bring valuable and diverse experience to Petauri Advisors," said Steve O'Malley, President, Petauri Advisors.